Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes

被引:21
作者
Carraresi, L
Tripodi, SA
Mulder, LCF
Bertini, S
Nuti, S
Schuerfeld, K
Cintorino, M
Bensi, G
Rossini, M
Mora, M
机构
[1] Univ Siena, Dept Physiopathol & Expt Med, I-53100 Siena, Italy
[2] Univ Siena, Inst Pathol Anat & Histol, I-53100 Siena, Italy
[3] Chiron Res Ctr, I-53100 Siena, Italy
关键词
human Papillomavirus type 16; E6/E7; oncogenes; transgenic mice; lung carcinomas; thymic hyperplasia;
D O I
10.1038/sj.onc.1205007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human Papillomavirus type 16 (HPV-16) is the cause of both benign lesions and ano-genital cancers. In HPV-associated cancers the transforming properties of the expressed viral E6 and E7 proteins have been revealed by a number of different assays. We have generated transgenic mice expressing HPV-16 E6/E7 genes under the control of the murine keratin 5 gene promoter, which should confer cell-type specific expression in the basal cells of squamous stratified epithelia. Transgenic mice developed thymic hyperplasia and lung neoplasia with 100% frequency, the thymus showing a size increase at 2 months and reaching the maximum dimension at 6 months, when lung carcinomas appeared. After this time the size of hyperplastic thymi decreased, while malignant formations invaded the mediastinal area. Hepatic metastasis could be also observed in some of the animals at the autopsy and death invariably occurred around 10 - 11 months of age.
引用
收藏
页码:8148 / 8153
页数:6
相关论文
共 86 条
[1]   PROGRESSIVE SQUAMOUS EPITHELIAL NEOPLASIA IN K14-HUMAN PAPILLOMAVIRUS TYPE-16 TRANSGENIC MICE [J].
ARBEIT, JM ;
MUNGER, K ;
HOWLEY, PM ;
HANAHAN, D .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4358-4368
[2]  
ARBEIT JM, 1993, AM J PATHOL, V142, P1187
[3]   TARGETED EXPRESSION OF THE E6 AND E7 ONCOGENES OF HUMAN PAPILLOMAVIRUS TYPE-16 IN THE EPIDERMIS OF TRANSGENIC MICE ELICITS GENERALIZED EPIDERMAL HYPERPLASIA INVOLVING AUTOCRINE FACTORS [J].
AUEWARAKUL, P ;
GISSMANN, L ;
CIDARREGUI, A .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :8250-8258
[4]   IDENTIFICATION OF HUMAN PAPILLOMAVIRUS TYPE-18 TRANSFORMING GENES IN IMMORTALIZED AND PRIMARY-CELLS [J].
BEDELL, MA ;
JONES, KH ;
GROSSMAN, SR ;
LAIMINS, LA .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1247-1255
[5]  
Bol D, 1998, MOL CARCINOGEN, V21, P2, DOI 10.1002/(SICI)1098-2744(199801)21:1<2::AID-MC2>3.0.CO
[6]  
2-R
[7]  
Boyer SN, 1996, CANCER RES, V56, P4620
[8]   Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease [J].
Butel, JS .
CARCINOGENESIS, 2000, 21 (03) :405-426
[9]   PROBING KERATINOCYTE AND DIFFERENTIATION SPECIFICITY OF THE HUMAN K5 PROMOTER INVITRO AND IN TRANSGENIC MICE [J].
BYRNE, C ;
FUCHS, E .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) :3176-3190
[10]   ADENOVIRUS-E1A, SIMIAN VIRUS-40 TUMOR-ANTIGEN, AND HUMAN PAPILLOMAVIRUS-E7 PROTEIN SHARE THE CAPACITY TO DISRUPT THE INTERACTION BETWEEN TRANSCRIPTION FACTOR-E2F AND THE RETINOBLASTOMA GENE-PRODUCT [J].
CHELLAPPAN, S ;
KRAUS, VB ;
KROGER, B ;
MUNGER, K ;
HOWLEY, PM ;
PHELPS, WC ;
NEVINS, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4549-4553